These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36110386)

  • 1. Fragment Ligands of the m
    Nai F; Nachawati R; Zálešák F; Wang X; Li Y; Caflisch A
    ACS Med Chem Lett; 2022 Sep; 13(9):1500-1509. PubMed ID: 36110386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
    Nakagawa N; Sonohara F; Tanaka K; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-145 Modulates
    Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
    J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
    [No Abstract]   [Full Text] [Related]  

  • 4. The biological function of m6A reader YTHDF2 and its role in human disease.
    Wang JY; Lu AQ
    Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
    Liu R; Jia Y; Kong G; He A
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m
    Chen X; Zhou X; Wang X
    Exp Hematol Oncol; 2022 Apr; 11(1):21. PubMed ID: 35382893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine-dependent regulation of messenger RNA stability.
    Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
    Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
    Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
    Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms Driving mRNA Degradation by m
    Lee Y; Choe J; Park OH; Kim YK
    Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA.
    Theler D; Dominguez C; Blatter M; Boudet J; Allain FH
    Nucleic Acids Res; 2014 Dec; 42(22):13911-9. PubMed ID: 25389274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBW7 suppresses ovarian cancer development by targeting the N
    Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
    Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for the Discriminative Recognition of N6-Methyladenosine RNA by the Human YT521-B Homology Domain Family of Proteins.
    Xu C; Liu K; Ahmed H; Loppnau P; Schapira M; Min J
    J Biol Chem; 2015 Oct; 290(41):24902-13. PubMed ID: 26318451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of BAZ2A bromodomain ligands.
    Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A
    Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of the m6A RNA-Binding Proteins
    Luo Q; Guo Y; Xiao Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
    Front Med (Lausanne); 2022; 9():922219. PubMed ID: 35755020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
    Xu J; Shang Y; Qin X; Gai Y; Cai F; Xiao H; Zhou C; Fu Y; Ge X
    Contrast Media Mol Imaging; 2022; 2022():1087622. PubMed ID: 35924072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.
    Pan Z; Zhang Q; Liu X; Zhou H; Jin T; Hao LY; Xie L; Zhang M; Yang XX; Sun ML; Xue ZY; Tao Y; Ye XC; Shen W; Cao JL
    Pain; 2021 Jul; 162(7):1960-1976. PubMed ID: 34130310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
    Liu J; Gao M; Xu S; Chen Y; Wu K; Liu H; Wang J; Yang X; Wang J; Liu W; Bao X; Chen J
    Cell Rep; 2020 Sep; 32(10):108120. PubMed ID: 32905781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.
    Du H; Zhao Y; He J; Zhang Y; Xi H; Liu M; Ma J; Wu L
    Nat Commun; 2016 Aug; 7():12626. PubMed ID: 27558897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.